In 2018 the Clinical Genome Resource (ClinGen) re-examined the gene-disease relationship for CACNA1C and Brugada Syndrome, and classified the evidence supporting a causal role for CACNA1C in Brugada Syndrome as limited (12). The gene discussed is CACNA1C; the disease is Brugada syndrome.